Abstract: In a software system (200/210/220) with a business application (200), database migration from a source database (210) to a physically different target database (230) is performed by a migration tool (260) that evaluates database instructions (201) that the application (200) consecutively sends to the source database (210). The migration tool (260) stores representations (254, 255) of an action type (205, D, I, U) and of a key (231) in a log table (250) when an action type coincides with a predetermined action type (D, I, U); copies source table entries to the target table (240); and adjusts entries in the target table that have keys represented in the log table (250). During migration, the application (200) and the source table continue communicating.

Abstract: Compounds having the formula (I), are useful as p38 kinase inhibitors, wherein R4 and R5 are hydrogen, halogen, cyano, haloalkyl, or haloalkoxy, but are not both hydrogen; R6 and R7 are optional substituents, and Q is a non-aromatic moiety as defined in the specification.

Abstract: The present invention provides compounds of the Formula I and II: wherein R1, R3, W, Z, X1, X2, Ar1, R8 and R9 are as defined herein, and methods and intermediates for their preparation and uses thereof.

Abstract: The present invention discloses compounds corresponding to the formula wherein A, X, Y, R, R1 and R2 are as defined within, pharmaceutical formulations, methods of making and uses thereof.

Abstract: The present invention discloses compounds corresponding to formula wherein A, R, X, Y, R, R1 and R2 are as defined above, pharmaceutical formulations, methods of making and uses thereof.

Abstract: This invention relates to new tetronic and tetramic acid derivatives with beta-secretase inhibitory activity of formula I: wherein R1, R2, R3, R4, R5, R5?, R6 and R6? are as defined hereinabove, to processes for their preparation, compositions containing said tetronic and tetramic acid derivatives and their use in the treatment and prevention of diseases modulated by an inhibitor of ?-secretase, such as Alzheimer's disease.

Abstract: A harvesting platform comprising a conveyor belt assembly being located rearwardly from a cutter bar. The conveyor belt assembly comprises a first roller and a second roller around which a conveyor belt runs. The rollers are fastened to each other by mounting elements. The conveyor belt assembly is pivotally mounted to the floor of the platform so it can be pivoted upward from the floor.

Abstract: Compounds having the formula (I), are useful as p38 kinase inhibitors, wherein R4 and R5 are hydrogen, halogen, cyano, haloalkyl, or haloalkoxy, but are not both hydrogen; R6 and R7 are optional substituents, and Q is a non-aromatic moiety as defined in the specification.

Abstract: A crop harvesting mechanism having a reel assembly with a reel that is rotatably supported at each end by a respective reel support. A reel carrier arm is provided for each of the reel supports and the supports are movable along the reel carrier arm. A horizontal adjustment actuator moves the reel support along the reel carrier arms over an adjustment range. The reel carrier arms are constructed with an upward or downward oriented curve, inside of the adjustment range over which the reel holding devices can be shifted by the actuator. The reel operates below a cutting bar in its forward position and in a position moved further back that is above and behind the cutting bar so that collisions are avoided.

Abstract: The invention is concerned with novel carbocyclyl fused cyclic amines of formula (I) wherein A, X1 to X3, Y1 to Y3, Z, R1, R2, m and n are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit the coagulation factor Xa and can be used as medicaments.

Abstract: The present invention provides compounds of the Formula I and II: wherein R1, R3, W, Z, X1, X2, Ar1, R8 and R9 are as defined herein, and methods and intermediates for their preparation and uses thereof.

Abstract: The invention pertains to a combine head with a frame to which a transverse conveyor spiral is secured that extends transversely with respect to the forward direction of the combine head, where several conveyor belt assemblies are pre-arranged at this transverse conveyor spiral in a laterally sequential manner in the forwa4rd direction and are equipped with conveyor belts, and in the harvesting mode of operation, convey material to be harvested rearward to the transverse conveyor spiral, which in turn conveys it transversely with respect to the forward direction and toward the middle of the combine head, wherein a cover is present between adjacent conveyor belt assemblies in order to seal off the inner zones of the conveyor belt assemblies.

Abstract: The invention is concerned with novel mandelic acid derivatives of formula (I) wherein R1 to R10, X and Y are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These compounds inhibit the formation of coagulation factors Xa, IXa and thrombin induced by factor VIIa and tissue factor.

Abstract: The present invention discloses compounds corresponding to formula wherein A, R, X, Y, R, R1 and R2 are as defined above, pharmaceutical formulations, methods of making and uses thereof.

Abstract: A crop harvesting mechanism having a reel assembly with a reel that is rotatably supported at each end by a respective reel support. A reel carrier arm is provided for each of the reel supports and the supports are movable along the reel carrier arm. A horizontal adjustment actuator moves the reel support along the reel carrier arms over an adjustment range. The reel carrier arms are constructed with an upward or downward oriented curve, inside of the adjustment range over which the reel holding devices can be shifted by the actuator. The reel operates below a cutting bar in its forward position and in a position moved further back that is above and behind the cutting bar so that collisions are avoided.

Abstract: A harvesting platform comprising a conveyor belt assembly being located rearwardly from a cutter bar. The conveyor belt assembly comprises a first roller and a second roller around which a conveyor belt runs. The rollers are fastened to each other by mounting elements. The conveyor belt assembly is pivotally mounted to the floor of the platform so it can be pivoted upward from the floor.

Abstract: Compounds having the formula (I), 1

Abstract: In a software system (200/210/220) with a business application (200), database migration from a source database (210) to a physically different target database (230) is performed by a migration tool (260) that evaluates database instructions (201) that the application (200) consecutively sends to the source database (210). The migration tool (260) stores representations (254, 255) of an action type (205, D, I, U) and of a key (231) in a log table (250) when an action type coincides with a predetermined action type (D, I, U); copies source table entries to the target table (240); and adjusts entries in the target table that have keys represented in the log table (250). During migration, the application (200) and the source table continue communicating.

Abstract: The invention is concerned with novel mandelic acid derivatives of formula (I) 1

Abstract: The present invention provides compounds of the Formula I and II: 1